Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
MONTREAL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX) announced today that it has filed and is in the process of maili...
How might the interim order and the proxy materials impact TH's stock liquidity and price volatility leading up to the September 12 special meeting?
What is the timeline for required regulatory and shareholder approvals, and when is the transaction expected to close?
What are the specific terms and valuation of the acquisition, including the share exchange ratio, and how will they affect current TH shareholders?
11 days ago